Acute Pancreatitis: Clinical Trials

20 trials for Acute Pancreatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 5 recruiting, 3 unknown, 1 terminated. 20 Phase 2, 4 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 220Completed 11, Recruiting 5, Unknown 3, Terminated 1
Phase 14Unknown 2, Completed 1, Recruiting 1
Phase 34Completed 3, Unknown 1

Follow Acute Pancreatitis: new trials by email Literature Review of Acute Pancreatitis trials Research Report on Acute Pancreatitis

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of SGC001 Injection for Predicted Severe Acute Pancreatitis to Assess Safety, Tolerability and Preliminary Efficacy
SGC001 injection, Placebo - Acute Pancreatitis
Phase 2RecruitingBeijing Sungen Biomedical Technology Co., Ltd1292026-09-302026-10-13
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
RABI-767 - Acute Pancreatitis
Phase 2RecruitingPanafina, Inc.362024-06-282026-08-05
Prophylactic Tributyrin Supplementation in Acute Pancreatitis
Micro-encapsulated granules of tributyrin (intervention), Micro-encapsulated granules of sunflower oil (placebo) - Acute Pancreatitis
Phase 2RecruitingSt. Antonius Hospital922024-02-122024-06-20
Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid
Ketorolac, Opioid - Acute Pancreatitis
Phase 2TerminatedBoston Children's Hospital232022-03-152026-01-08
Effects of Peripherally Acting µ-opioid Receptor Antagonists on Acute Pancreatitis
Placebo treatment, Methylnaltrexone treatment - Acute Pancreatitis
Phase 2 / Phase 3CompletedAsbjørn Mohr Drewes1052021-05-142023-04-21
A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS
CM-4620 Injectable Emulsion or CM-4620-IE, Placebo - Acute Pancreatitis, Systemic Inflammatory Response Syndrome
Phase 2CompletedCalciMedica, Inc.2162021-03-242026-08-24
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
CM4620 - Acute Pancreatitis
Phase 1 / Phase 2RecruitingSt. Jude Children's Research Hospital422020-09-042026-06-03
Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)
Infusion of 5 mg/kg Infliximab, Infusion of 10 mg/kg Infliximab, 0.9% Sodium Chloride (Placebo) - Acute Pancreatitis
Phase 2RecruitingUniversity of Liverpool2402019-05-012026-07-06
A PK/PD Study of CM4620-IE in Patients With Acute Pancreatitis
CM4620-IE - Acute Pancreatitis
Phase 2CompletedCalciMedica, Inc.72019-01-062022-05-03
CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS
CM4620 Injectable Emulsion (Low Dose), CM4620 Injectable Emulsion (High Dose) - Acute Pancreatitis, Systemic Inflammatory Response Syndrome
Phase 2CompletedCalciMedica, Inc.212018-03-122026-03-30
Fecal Microbiota Transplantation for Pancreatitis
Fecal Microbiota Transplantation, normal saline - Acute Pancreatitis, Intestinal Bacteria Flora Disturbance
Phase 2CompletedThe First Affiliated Hospital of Nanchang University602017-11-182021-04-14
Fecal Microbiota Transplantation (FMT) for Severe Acute Pancreatitis(SAP)
Fecal Microbiota Transplantation, normal saline - Acute Pancreatitis, Intestinal Bacteria Flora Disturbance
Phase 1 / Phase 2UnknownFirst Affiliated Hospital of Chengdu Medical College802016-12-012017-01-11
Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis
Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment - Acute Pancreatitis
Phase 2CompletedNational Cancer Institute (NCI)82016-09-192022-12-13
Enhanced Recovery in Acute Pancreatitis
Enhanced recovery protocol - Acute Pancreatitis
Phase 2CompletedKaiser Permanente462016-06-012017-05-30
Epidural Anesthesia in Acute Pancreatitis
Epidural anesthesia, intravenous analgesia - Acute Pancreatitis
Phase 2 / Phase 3UnknownHospital General Naval de Alta Especialidad - Escuela Medico Naval602015-11-012016-01-11
Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension
Neostigmine Methylsulfate 1 MG/ML, Conservative treatment - Acute Pancreatitis, Intra-abdominal Hypertension
Phase 2CompletedThe First Affiliated Hospital of Nanchang University802015-09-012021-10-05
The Clinical Study of Acute Pancreatitis Treated by TongFuSan
TongFuSan - Acute Pancreatitis
Phase 1 / Phase 2UnknownBeijing Friendship Hospital1002014-03-012014-07-30
Use of Streptokinase for Enhancement of Percutaneous Drainage of Pancreatic Necrosis
streptokinase, Saline irrigation - Acute Pancreatitis
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh282013-05-012016-07-07
Comparing the Outcome in Patients of Acute Pancreatitis, With and Without Prophylactic Antibiotics
Meropenem - Acute Pancreatitis
Phase 1 / Phase 2CompletedBenazir Bhutto Hospital, Rawalpindi902013-01-012014-08-08
MIld to MOderate Acute Pancreatitis: Early naSogastric Tube Feeding Compared With pAncreas Rest (MIMOSA)
Enteral tube feeding - Acute Pancreatitis
Phase 2 / Phase 3CompletedUniversity of Auckland, New Zealand352010-05-012013-01-08

Narrower conditions

Pancreatitis (20)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Agnosia (1)  ·  Intra-Abdominal Hypertension (1)  ·  Pancreatitis, Acute Necrotizing (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Digestive System Diseases (20)  ·  Pancreatic Diseases (20)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Inflammation (2)  ·  Pathologic Processes (2)  ·  Shock (2)  ·  Cardiovascular Diseases (1)  ·  Compartment Syndromes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)

Interventions

Fecal Microbiota Transplantation (2)  ·  Saline Solution (2)  ·  zegocractin (2)  ·  Analgesics, Opioid (1)  ·  Anesthesia, Epidural (1)  ·  Conservative Treatment (1)  ·  Enteral Nutrition (1)  ·  Hydromorphone (1)  ·  Infliximab (1)  ·  Ketorolac (1)  ·  Ketorolac Tromethamine (1)  ·  Meropenem (1)  ·  Methods (1)  ·  Morphine (1)  ·  Neostigmine (1)

Sponsors

CalciMedica, Inc. (3)  ·  The First Affiliated Hospital of Nanchang University (2)  ·  Asbjørn Mohr Drewes (1)  ·  Beijing Friendship Hospital (1)  ·  Beijing Sungen Biomedical Technology Co., Ltd (1)  ·  Benazir Bhutto Hospital, Rawalpindi (1)  ·  Boston Children's Hospital (1)  ·  First Affiliated Hospital of Chengdu Medical College (1)  ·  Hospital General Naval de Alta Especialidad - Escuela Medico Naval (1)  ·  Kaiser Permanente (1)  ·  National Cancer Institute (NCI) (1)  ·  Panafina, Inc. (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  St. Antonius Hospital (1)  ·  St. Jude Children's Research Hospital (1)

Countries

United States (8)  ·  China (5)  ·  India (3)  ·  Denmark (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Pakistan (1)  ·  United Kingdom (1)

Top investigators

Sudarshan Hebbar, MD (3)  ·  Nonghua Lv, MD (2)  ·  Amit Grover, MB BCh BAO (1)  ·  Aurora Guadalupe Ruiz Sandoval, anesthesia (1)  ·  Bechien U Wu, MD, MPH (1)  ·  Bilal Altaf, MBBS, FCPS I (1)  ·  Bin Miao, PHD (1)  ·  Chao Wang, PHD (1)  ·  Dinghua Xu, graduate (1)  ·  Fazal H Shah, MBBS, FCPS I (1)  ·  Fengwu Li, graduate (1)  ·  H. C. van Santvoort, dr. prof. (1)  ·  Hong Wang, Graduate (1)  ·  Li Fang, Ph.D (1)

Results publications

PMID 16521220, PMID 18191686, PMID 18388680, PMID 20012652, PMID 21562445, PMID 23340042, PMID 24054878, PMID 25685727, PMID 30629020, PMID 33939666, PMID 34924020, PMID 35083238, PMID 35241135, PMID 38916223, PMID 41938843, PMID 42760074, PMID 9539611

NIH funding

2017 (1), N01CN00035 (1), P30CA060553 (1)